These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22426833)

  • 1. α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system.
    Mollenhauer B; Trautmann E; Otte B; Ng J; Spreer A; Lange P; Sixel-Döring F; Hakimi M; Vonsattel JP; Nussbaum R; Trenkwalder C; Schlossmacher MG
    J Neural Transm (Vienna); 2012 Jul; 119(7):739-46. PubMed ID: 22426833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid levels of alpha-synuclein, amyloid β, tau, phosphorylated tau, and neuron-specific enolase in patients with Parkinson's disease, dementia with Lewy bodies or other neurological disorders: Their relationships with cognition and nuclear medicine imaging findings.
    Katayama T; Sawada J; Kikuchi-Takeguchi S; Kano K; Takahashi K; Saito T; Okizaki A; Hasebe N
    Neurosci Lett; 2020 Jan; 715():134564. PubMed ID: 31733322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique glycan-isoform of transferrin in cerebrospinal fluid: A potential diagnostic marker for neurological diseases.
    Hoshi K; Matsumoto Y; Ito H; Saito K; Honda T; Yamaguchi Y; Hashimoto Y
    Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2473-2478. PubMed ID: 28711405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
    Antonelou RCh; Emmanouilidou E; Gasparinatos G; Velona T; Voumvourakis KI; Stefanis L
    J Neurochem; 2015 Aug; 134(4):748-55. PubMed ID: 25962981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of brain-derived proteins in cerebrospinal fluid.
    Reiber H
    Clin Chim Acta; 2001 Aug; 310(2):173-86. PubMed ID: 11498083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipocalin-type prostaglandin D synthase (beta-trace) in cerebrospinal fluid: a useful marker for the diagnosis of normal pressure hydrocephalus.
    Mase M; Yamada K; Shimazu N; Seiki K; Oda H; Nakau H; Inui T; Li W; Eguchi N; Urade Y
    Neurosci Res; 2003 Dec; 47(4):455-9. PubMed ID: 14630351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain.
    Beatman EL; Massey A; Shives KD; Burrack KS; Chamanian M; Morrison TE; Beckham JD
    J Virol; 2015 Dec; 90(6):2767-82. PubMed ID: 26719256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus.
    Nakajima M; Miyajima M; Ogino I; Akiba C; Sugano H; Hara T; Fusegi K; Karagiozov K; Arai H
    J Neurol Sci; 2015 Oct; 357(1-2):88-95. PubMed ID: 26169158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of motor performance, brain biochemistry and histology of two A30P α-synuclein transgenic mouse strains.
    Piltonen M; Savolainen M; Patrikainen S; Baekelandt V; Myöhänen TT; Männistö PT
    Neuroscience; 2013 Feb; 231():157-68. PubMed ID: 23219665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases.
    Tumani H; Nau R; Felgenhauer K
    Ann Neurol; 1998 Dec; 44(6):882-9. PubMed ID: 9851432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40).
    Vanderstichele H; Demeyer L; Janelidze S; Coart E; Stoops E; Mauroo K; Herbst V; François C; Hansson O
    Alzheimers Res Ther; 2017 Jun; 9(1):40. PubMed ID: 28587660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular specificity of the blood-CSF barrier for albumin transfer across the choroid plexus epithelium.
    Liddelow SA; Dzięgielewska KM; Møllgård K; Whish SC; Noor NM; Wheaton BJ; Gehwolf R; Wagner A; Traweger A; Bauer H; Bauer HC; Saunders NR
    PLoS One; 2014; 9(9):e106592. PubMed ID: 25211495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
    Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
    Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein.
    Landeck N; Hall H; Ardah MT; Majbour NK; El-Agnaf OM; Halliday G; Kirik D
    Mol Neurodegener; 2016 Aug; 11(1):61. PubMed ID: 27549140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential sources of interference with the highly sensitive detection and quantification of alpha-synuclein seeds by qRT-QuIC.
    Ruf VC; Shi S; Schmidt F; Weckbecker D; Nübling GS; Ködel U; Mollenhauer B; Giese A
    FEBS Open Bio; 2020 May; 10(5):883-893. PubMed ID: 32190992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats.
    Van Den Berge N; Ferreira N; Gram H; Mikkelsen TW; Alstrup AKO; Casadei N; Tsung-Pin P; Riess O; Nyengaard JR; Tamgüney G; Jensen PH; Borghammer P
    Acta Neuropathol; 2019 Oct; 138(4):535-550. PubMed ID: 31254094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.
    Butkovich LM; Houser MC; Chalermpalanupap T; Porter-Stransky KA; Iannitelli AF; Boles JS; Lloyd GM; Coomes AS; Eidson LN; De Sousa Rodrigues ME; Oliver DL; Kelly SD; Chang J; Bengoa-Vergniory N; Wade-Martins R; Giasson BI; Joers V; Weinshenker D; Tansey MG
    J Neurosci; 2020 Sep; 40(39):7559-7576. PubMed ID: 32868457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small cisterno-lumbar gradient of phosphorylated Tau protein in geriatric patients with suspected normal pressure hydrocephalus.
    Djukic M; Spreer A; Lange P; Bunkowski S; Wiltfang J; Nau R
    Fluids Barriers CNS; 2016 Aug; 13(1):15. PubMed ID: 27581842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study.
    Kruse N; Persson S; Alcolea D; Bahl JM; Baldeiras I; Capello E; Chiasserini D; Bocchio Chiavetto L; Emersic A; Engelborghs S; Eren E; Fladby T; Frisoni G; García-Ayllón MS; Genc S; Gkatzima O; Heegaard NH; Janeiro AM; Kováčech B; Kuiperij HB; Leitão MJ; Lleó A; Martins M; Matos M; Mollergard HM; Nobili F; Öhrfelt A; Parnetti L; de Oliveira CR; Rot U; Sáez-Valero J; Struyfs H; Tanassi JT; Taylor P; Tsolaki M; Vanmechelen E; Verbeek MM; Zilka N; Blennow K; Zetterberg H; Mollenhauer B
    Neurobiol Aging; 2015 Sep; 36(9):2587-96. PubMed ID: 26093515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.